Argonaute RNA

Argonaute RNA develops SiRNA drugs for cardiometabolic diseases, leveraging a team with extensive experience from leading pharmaceutical companies

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical development

Model

01Company Overview

Argonaute RNA develops SiRNA drugs for cardiometabolic diseases, leveraging a team with extensive experience from leading pharmaceutical companies.

02Backed By1 investor

03Similar Companies

ST

Switch Therapeutics

Biotech & Life Sciences

→

AP

AP

IM

K

04Startup DNA

8

signals

Sectors
Business Model
Technology